These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32783216)

  • 1. Abobotulinum toxin A for periorbital facial rejuvenation: impact on ocular refractive parameters.
    Eftekhari MH; Aghaei H; Kangari H; Bahrami M; Eftekhari S; Tabatabaee SM; Shahraki K; Bahrami M; Broumand MG
    Clin Exp Optom; 2021 Jan; 104(1):115-118. PubMed ID: 32783216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eighteen-point abobotulinum toxin a upper face rejuvenation: an eye plastic perspective on 845 subjects.
    Kashkouli MB; Amani A; Jamshidian-Tehrani M; Yousefi S; Jazayeri AA
    Ophthalmic Plast Reconstr Surg; 2014; 30(3):219-24. PubMed ID: 24481513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients.
    Blitzer A; Binder WJ; Aviv JE; Keen MS; Brin MF
    Arch Otolaryngol Head Neck Surg; 1997 Apr; 123(4):389-92. PubMed ID: 9109785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis.
    Jia Z; Lu H; Yang X; Jin X; Wu R; Zhao J; Chen L; Qi Z
    Aesthetic Plast Surg; 2016 Oct; 40(5):769-77. PubMed ID: 27495260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial.
    Zimbler MS; Holds JB; Kokoska MS; Glaser DA; Prendiville S; Hollenbeak CS; Thomas JR
    Arch Facial Plast Surg; 2001; 3(3):165-9. PubMed ID: 11497500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sixth nerve palsy following botulinum toxin injection for facial rejuvenation.
    Dolar Bilge A; Sadigov F; Salar-Gomceli S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):193-194. PubMed ID: 27558865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study.
    Keen M; Blitzer A; Aviv J; Binder W; Prystowsky J; Smith H; Brin M
    Plast Reconstr Surg; 1994 Jul; 94(1):94-9. PubMed ID: 8016257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and complications of a new technique of Abobotulinum-toxin A (Dysport) injection in patients with glabellar lines.
    Karbassi E; Nakhaee N; Zamanian M
    J Cosmet Dermatol; 2019 Feb; 18(1):55-58. PubMed ID: 29569830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.
    Lowe NJ
    Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full-face treatment with onabotulinumtoxinA: Results from a single-center study.
    D'Emilio R; Rosati G
    J Cosmet Dermatol; 2020 Apr; 19(4):809-816. PubMed ID: 31486568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Split face comparison between common concentration vs double dilution of intradermal abobotulinum toxin type A (Dysport) injection for facial lifting in Asians.
    Sirithanabadeekul P; Lapsomboonsiri S; Rungjang A; Thanasarnaksorn W
    J Cosmet Dermatol; 2018 Jun; 17(3):355-360. PubMed ID: 29878718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Employing microbotox technique for facial rejuvenation and face-lift.
    Iranmanesh B; Khalili M; Mohammadi S; Amiri R; Aflatoonian M
    J Cosmet Dermatol; 2022 Oct; 21(10):4160-4170. PubMed ID: 35064633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use].
    Sheen-Ophir S; Almog Y
    Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of periorbital rejuvenation with botulinum toxin A using two different protocols.
    Lee CJ; Kim SG; Han JY
    Aesthetic Plast Surg; 2006; 30(1):65-70. PubMed ID: 16404647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study.
    Gordin EA; Luginbuhl AL; Ortlip T; Heffelfinger RN; Krein H
    JAMA Facial Plast Surg; 2014; 16(3):193-8. PubMed ID: 24699554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An observational study on glabellar wrinkle patterns in Indians.
    Kamat A; Quadros T
    Indian J Dermatol Venereol Leprol; 2019; 85(2):182-189. PubMed ID: 29620040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.